The condition arises from complex interactions between genetic, metabolic, and environmental factors
* Weight loss based on self-reported member data on a Found program including GLP-1 injections, as of February 2026
Clinical studies have shown that patients using GLP-1 medications may lose up to 1520% of their body weight when combined with proper medical care and lifestyle adjustments
Getting adequate energy support during semaglutide treatment requires attention to iron status, especially for women with heavy menstrual periods
However, electrophysiological studies revealed that GLP-1 or exendin-4 does not change the spontaneous firing activity as well as the synaptic transmission suggesting lack of functional GLP-1R in PPG neurons (Hisadome et al., 2010)
When food becomes scarce, from an evolutionary perspective, maintaining metabolically expensive tissue makes little sense